Kathleen Richton
Vermogen: 11 937 $ op 30-06-2026
Vermogen: 11 937 $ op 30-06-2026
Ms. Kathleen Richton is a Senior VP, Chief Financial & Accounting Officer at enGene Therapeutics, Inc. Ms. Richton was previously employed as a Vice President & Controller by Sunovion Pharmaceuticals, Inc. She received her undergraduate degree from Bentley University and a graduate degree from Bentley University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 16-07-2026 | 6.900 ( 0,01% ) | 11 937 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Financieel Directeur/CFO | 16-07-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Comptroller/Controller/Auditor | 01-07-2023 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Bentley University
Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
enGene Holdings, Inc.
enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau